CHS reported an operating income of $542 million (4.3% margin) in 2024, down from a $957 million gain (7.7% margin) in 2023. Other expenses, primarily $860 million in interest costs, left CHS with a $362 million net operating loss (-2.9% margin) for 2024, compared to a $16 million net operating gain (0.1% margin) the previous year.
“We continue to make meaningful progress in key strategic areas, and we were especially pleased with demand for our services and strong same-store volume growth,” CEO Tim Hingtgen said in the for-profit health system’s Feb. 18 financial report.
Here are CHS’ five highest-earning executives in 2024:
1. Tim L. Hingtgen, CEO
- Salary: $1.33 million
- Restricted stock awards: $1.72 million
- Option awards: $438,000
- Non-equity incentive plan: $3.23 million
- Changes in pension value and non-qualified deferred compensation earnings: $896,801
- Other compensation: $21,315
- Total 2024 compensation: $7.6 million
- Total 2023 compensation: $8.3 million
2. Kevin J. Hammons, President and CFO
- Salary: $795,675
- Restricted stock awards: $774,900
- Option awards: $197,100
- Non-equity incentive plan: $1.14 million
- Changes in pension value and non-qualified deferred compensation earnings:$547,926
- Other compensation: $17,474
- Total 2024 compensation: $3.5 million
- Total 2023 compensation: $3.8 million
3. Lynn T. Simon, M.D., President, Healthcare Innovation & Chief Medical Officer
- Salary: $679,691
- Restricted stock awards: $344,400
- Option awards: $87,600
- Non-equity incentive plan: $815,661
- Changes in pension value and non-qualified deferred compensation earnings: $135,405
- Other compensation: $36,770
-
- Total 2023 compensation: $2.1 millionTotal 2024 compensation: $2.1 million
4. Kevin A. Stockton, Executive Vice President of Operations and Development
- Salary: $710,000
- Restricted stock awards: $344,400
- Option awards: $87,600
- Non-equity incentive plan: $852,036
- Changes in pension value and non-qualified deferred compensation earnings: $162,488
- Other compensation: $10,970
- Total 2024 compensation: $2.2 million
- Total 2023 compensation: $1.6 million
5. Chad A. Campbell, Regional President
- Salary: $672,000
- Restricted stock awards: $215,250
- Option awards: $54,750
- Non-equity incentive plan: $806,431
- Changes in pension value and non-qualified deferred compensation earnings: $161,399
- Other compensation: $15,650
- Total 2024 compensation: $1.9 million
- Total 2023 compensation: $1.7 million
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
